According to documents obtained by Reuters, Dendreon analyzed the data in its key clinical trial for the prostate cancer treatment Provenge differently than their pre-specified goal stipulated...
See which companies are seeing their stock prices at annual lows right now...
Here's why these healthcare stocks are moving now...
Your Cheat Sheet to the top healthcare business news...
Here's why these health stocks are moving now...
The Nasdaq was down 0.65 percent on the day and strands at 3,116. These healthcare stocks helped to move the exchange...
Difficulties still haunt the drug manufacturer as Provenge sells more slowly than expected...
Your Cheat Sheet to the top healthcare business news...
Your Cheat Sheet to the top healthcare business news...
It's always a good strategy to track transparency of pundits...
Dendreon's Top Institutional Shareholders for Q2 2012
Your Cheat Sheet to the top healthcare business news...
Your Cheat Sheet to the top healthcare business news...
Here's what analysts had to say about these companies today...
Your Cheat Sheet to the top healthcare business news...